Oxidative stress and cardiovascular risk in overweight children in an exercise intervention program

Childhood Obesity

Volumn 9, Issue 1, 2013, Pages 15-21

  Dennis, B Adam ^a   Ergul, Adviye ^a   Gower, Barbara A ^b   Allison, Jerry D ^a   Davis, Catherine L ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ISOPROSTANE DERIVATIVE; LIPID;

ANALYSIS OF VARIANCE; ARTICLE; BLOOD; BODY MASS; CARDIOVASCULAR DISEASE; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INTERVENTION STUDY; KINESIOTHERAPY; MALE; METABOLIC SYNDROME X; METABOLISM; OBESITY; OXIDATIVE STRESS; OXYGEN CONSUMPTION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHILD; CROSS-SECTIONAL STUDIES; EXERCISE THERAPY; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INTERVENTION STUDIES; ISOPROSTANES; LIPIDS; MALE; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS; OXYGEN CONSUMPTION; RISK FACTORS;

EID: 84873397192     PISSN: 21532168     EISSN: 21532176     Source Type: Journal    
DOI: 10.1089/chi.2011.0092     Document Type: Article

References (43)

1. Kadiiska MB, Gladen BC, Baird DD, et al. Biomarkers of oxidative stress study II: Are oxidation products of lipids, proteins, and DNA markers of CCL4 poisoning? Free Radic Biol Med 2005;38:698-710.
2. Balagopal PB, de Ferranti SD, Cook S, et al. Nontraditional risk factors and biomarkers for cardiovascular disease: Mechanistic, research, and clinical considerations for youth: A scientific statement from the American Heart Association. Circulation 2011;123:2749-2769.
3. Montuschi P, Barnes P, Roberts LJ, 2nd. Insights into oxidative stress: The isoprostanes. Curr Med Chem 2007;14:703-717.
4. Nishikawa T, Edelstein D, Brownlee M. The missing link: A single unifying mechanism for diabetic complications. Kidney Int Suppl 2000;77:S26-S30.
5. Sugamura K, Keaney JF Jr. Reactive oxygen species in cardiovascular disease. Free Radic Biol Med 2011;51:978-992.
6. Kelly AS, Steinberger J, Kaiser DR, et al. Oxidative stress and adverse adipokine profile characterize the metabolic syndrome in children. J Cardiometab Syndr 2006;1:248-252.
7. Araki S, Dobashi K, Yamamoto Y, et al. Increased plasma isoprostane is associated with visceral fat, high molecular weight adiponectin, and metabolic complications in obese children. Eur J Pediatr 2010;169:965-970.
8. Ostrow V, Wu S, Aguilar A, et al. Association between oxidative stress and masked hypertension in a multi-ethnic population of obese children and adolescents. J Pediatr 2011;158:628-633, e621.
9. Sinaiko AR, Steinberger J, Moran A, et al. Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation 2005;111:1985-1991.
10. Pou KM, Massaro JM, Hoffmann U, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: The Framingham Heart Study. Circulation 2007;116:1234-1241.
11. Reilly MP, Pratico D, Delanty N, et al. Increased formation of distinct F2 isoprostanes in hypercholesterolemia. Circulation 1998;98:2822-2828.
12. Roberts CK, Won D, Pruthi S, et al. Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. J Appl Physiol 2006;100:1657-1665.
13. Kelly AS, Steinberger J, Olson TP, et al. In the absence of weight loss, exercise training does not improve adipokines or oxidative stress in overweight children. Metabolism 2007;56: 1005-1009.
14. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: Improvements to the 1977 National Center For Health Statistics version. Pediatrics 2002;109:45-60.
15. Davis CL, Pollock NK, Waller JL, et al. Exercise dose and diabetes risk in overweight and obese children: A randomized, controlled trial. JAMA 2012;308:1103-1112.
16. Rowland TW. Aerobic Exercise Testing Protocols. Human Kinetics: Champaign, IL, 1993.
17. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription, 6th ed. Lippincott Williams & Wilkins: Baltimore, MD, 2000.
18. Owens S, Gutin B, Ferguson M, et al. Visceral adipose tissue and cardiovascular risk factors in obese children. J Pediatr 1998; 133:41-45.
19. Bassali R, Waller JL, Gower B, et al. Utility of waist circumference percentile for risk evaluation in obese children. Int J Pediatr Obes 2010;5:97-101.
20. YeckelCW, Weiss R, Dziura J, et al. Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin EndocrinolMetab 2004;89:1096-1101.
21. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495.
22. Abdul-Ghani MA, Williams K, DeFronzo RA, et al. What is the best predictor of future type 2 diabetes? Diabetes Care 2007;30: 1544-1548.
23. Sjaarda LG, Bacha F, Lee S, et al. Oral disposition index in obese youth from normal to prediabetes to diabetes: Relationship to clamp disposition index. J Pediatr 2012;161:51-57.
24. Zimmet P, Alberti KG, Kaufman F, et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 2007;8:299-306.
25. Fernandez JR, Redden DT, Pietrobelli A, et al. Waist circumference percentiles in nationally representative samples of African- American, European-American, and Mexican-American children and adolescents. J Pediatr 2004;145:439-444.
26. Barlow SE. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: Summary report. Pediatrics 2007; 120(Suppl 4):S164-S192.
27. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012;35(Suppl 1):S64-S71.
28. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Summary report. Pediatrics 2011;128(Suppl 5):S213-S256.
29. National High Blood Pressure Education Program (NHBPEP). The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114: 555-576.
30. Roberts CK, Chen AK, Barnard RJ. Effect of a short-term diet and exercise intervention in youth on atherosclerotic risk factors. Atherosclerosis 2007;191:98-106.
31. Roberts CK, Won D, Pruthi S, et al. Effect of a diet and exercise intervention on oxidative stress, inflammation and monocyte adhesion in diabetic men. Diabetes Res Clin Pract 2006;73:249-259.
32. Kelly AS, Jacobs DR Jr, Sinaiko AR, et al. Relation of circulating oxidized LDL to obesity and insulin resistance in children. Pediatr Diabetes 2010;11:552-555.
33. Keaney JF Jr, Larson MG, Vasan RS, et al. Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the Framingham study. Arterioscler Thromb Vasc Biol 2003;23: 434-439.
34. Pi J, Bai Y, Zhang Q, et al. Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes 2007;56:1783- 1791.
35. Leloup C, Tourrel-Cuzin C, Magnan C, et al. Mitochondrial reactive oxygen species are obligatory signals for glucose-induced insulin secretion. Diabetes 2009;58:673-681.
36. Meigs JB, Larson MG, Fox CS, et al. Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: The Framingham offspring study. Diabetes Care 2007;30:2529-2535.
37. McLaughlin T, Reaven G, Abbasi F, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol 2005;96:399-404.
38. Cracowski JL, Ploin D, Bessard J, et al. Formation of isoprostanes in children with type IIa hypercholesterolemia. J Cardiovasc Pharmacol 2001;38:228-231.
39. Martino F, Loffredo L, Carnevale R, et al. Oxidative stress is associated with arterial dysfunction and enhanced intima-media thickness in children with hypercholesterolemia: The potential role of nicotinamide-adenine dinucleotide phosphate oxidase. Pediatrics 2008;122:e648-e655.
40. Martino F, Pignatelli P, Martino E, et al. Early increase of oxidative stress and soluble CD40L in children with hypercholesterolemia. J Am Coll Cardiol 2007;49:1974-1981.
41. Bae JH, Bassenge E, Kim KB, et al. Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis 2001;155:517-523.
42. Redon J, Oliva MR, Tormos C, et al. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 2003;41:1096-1101.
43. Hansel B, Giral P, Nobecourt E, et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 2004;89: 4963-4971.